acne vulgaris
Conditions
Interventions
1:modified Qufeng Runfan Powder
2:placebo
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
15 Years to 30 Years
Inclusion criteria
Inclusion criteria: (1) The clinical diagnosis conforms to the diagnostic criteria of acne vulgaris, the grade I and II of Pillsbury classification method, and the syndrome differentiation criteria of dampness, toxin and blood stasis syndrome in traditional Chinese medicine; (2) Acne vulgaris patients aged 15-30 years in outpatient clinics; (3) untreated persons for nearly a week; (4) Those who consent to treatment and sign written informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnancy, trauma and other stress states; (2) those who had taken hormones, antibiotics, retinoic acid and other drugs for external use or oral administration within 2 weeks; those who received phototherapy within 2 weeks; (3) Patients with severe primary diseases, such as circulatory system, respiratory system, digestive system, urinary system, endocrine system and hematopoietic system, uncontrolled by routine medication; (4) Those who are participating in other drug clinical trials or who have participated in other clinical trials within one month; (5) People who have allergies to any kind of traditional Chinese medicine or matrix ingredients in this medicine have been exposed to it all over the body or locally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acne severity score; | — |
Secondary
| Measure | Time frame |
|---|---|
| visia;Soft Skin tester;DLQI; | — |
Countries
China
Contacts
Public ContactBai Yan-Ping
Beijing University of Chinese Medicine
Outcome results
None listed